BACKGROUND: Actions of angiotensin II may contribute to the progression of heart failure despite treatment with currently recommended drugs. We therefore evaluated the long-term effects of the addition of the angiotensin-receptor blocker valsartan to standard therapy for heart failure. METHODS: A to...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!